{"disease":{"id":"non-small-cell-lung-cancer-nsclc-with-high-pd-l1-expression-50-as-determined-by-an-fda-approved-test-in-patients-whose-tumors-have-progressed-during-or-following-platinum-containing-therapies.md","name":"non small cell lung cancer nsclc with high pd l1 expression 50 as determined by an fda approved test in patients whose tumors have progressed during or following platinum containing therapies.md"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}